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Background: Central hemodynamics help to maintain appropriate cerebral and other end-organ perfusion,
and may be altered with ageing and type 2 diabetes mellitus (T2DM). We aimed to determine the associations
between central hemodynamics and brain structure at rest and during exercise in people with and without T2DM.
Methods: In a sample of people with T2DM and healthy controls, resting and exercise measures of aortic reservoir
characteristics (including excess pressure integral [Pexcess]) and other central hemodynamics (including
augmentation index [AIx] and aortic pulse wave velocity [aPWV]) were recorded. Brain volumes (including gray
matter volume [GMV] and white matter lesions [WML]) were derived from magnetic resonance imaging (MRI) scans.
Multivariable linear regression was used to study the associations of hemodynamic variables with brain structure in
the two groups adjusting for age, sex, daytime systolic BP (SBP) and heart rate.
Results: There were 37 T2DM (63 ± 9 years; 47% male) and 37 healthy individuals (52 ± 8 years; 51% male). In T2DM,
resting aPWV was inversely associated with GMV (standardized β = −0.47, p = 0.036). In healthy participants, resting
Pexcess was inversely associated with GMV (β = −0.23, p = 0.043) and AIx was associated with WML volume (β = 0.52,
p = 0.021). There were no associations between exercise hemodynamics and brain volumes in either group.
Conclusions: Brain atrophy is associated with resting aortic stiffness in T2DM, and resting Pexcess in healthy
individuals. Central vascular mechanisms underlying structural brain changes may differ between healthy individuals
and T2DM.
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Vascular cognitive impairmentBackground
Type 2 diabetes mellitus (T2DM) is an important vascular
risk factor for cognitive impairment. It is associated with
brain atrophy [1], infarcts and cerebrovascular lesions
(white matter hyperintensity of presumed vascular origin
[WML]) [2], potentially leading to cognitive decline and
greater risk for dementia. Age-related vascular factors
such as hypertension and aortic stiffening are more pre-
valent in patients with T2DM [3] and may partly explain
the associated structural brain abnormalities [4-6]. Aortic* Correspondence: James.Sharman@menzies.edu.au
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unless otherwise stated.stiffening can limit buffering capacity of the large central
arteries such that small changes in cardiac stroke volume
can result in excessive rises in local pulsatile pressure [7].
These excess pressures may damage peripheral capillary
networks [8], which is of relevance to the brain as a high
flow organ with low resistance proximal large vessels and
an extensive microcirculation. Consequent damage to the
neurovascular unit may be a factor underlying the ob-
served brain atrophy in T2DM.
Aortic reservoir function plays a role in the maintenance
of normal central BP and may protect distal microcir-
culation by dampening excessive aortic pulsatile pressure,
as well as reducing peripheral pressure transmission [9].
The aortic reservoir pressure paradigm proposes that theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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aortic reservoir pressure component, representing prox-
imal aortic volume; and an excess pressure (Pexcess) com-
ponent, representing excess left ventricular work required
for stroke volume ejection, analogous to left ventricular
flow (Figure 1) [10,11]. Indeed, aortic reservoir pressure is
related to aortic stiffness (aortic pulse wave velocity
[aPWV]) and we have previously shown that reservoir
pressure, not backward pressure (i.e. from peripheral wave
reflections) is the largest contributory factor to an increase
in augmented pressure [12]. Increased Pexcess was recently
shown to independently predict adverse cardiovascular
events in patients with cardiovascular disease [13], pos-
sibly due to accelerated target organ damage, but this has
never been examined.
Although resting BP indices are clinically important,
hemodynamic responses to moderate exercise may have
stronger prognostic value in terms of cardiovascular risk
[14], suggesting that pathophysiological insight may be
gained from exercise hemodynamics beyond that of resting
conditions. This may be because individuals can spend a
large proportion of their day ambulatory [15] (doing some
form of light-moderate physical activity; standing, walking)
and the BP response to this type of lower intensity exercise
may, therefore, be a better representation of the chronic
BP load. Indeed, we have shown that independent of
resting BP, light-moderate exercise hemodynamics can
unveil BP abnormalities [16,17] and also predict kidney
function in older men [18]. We have also found that
patients with T2DM have abnormal responses at higherExcess 
pressure
Reservoir pressure 
Figure 1 Example aortic pressure waveform separated into
reservoir pressure and excess pressure. Total measured pressure
is equal to the sum of reservoir pressure and excess pressure. Aortic
reservoir pressure represents the cyclic increase in aortic volume
(aortic distension that occurs during systole) and decrease in volume
(aortic recoil that occurs during diastole). Excess pressure is
representative of the excess work required by the left ventricle for
ejection of stroke volume and is analogous to left ventricular flow.exercise intensities [19,20]. This study aimed to determine
associations between central hemodynamics, including aor-
tic reservoir characteristics, and brain structure in people




Eighty participants (T2DM n = 40, healthy controls n = 40)
were recruited from the community via local advertise-
ments. Exclusion criteria were; pregnancy, arrhythmia,
clinical history of cardiovascular disease (including coron-
ary artery disease, myocardial infarction, heart failure or
stroke), severe pulmonary disease and contraindication
to brain magnetic resonance imaging (MRI). T2DM was
determined by self-report of diagnosis by physician. All
participants gave informed consent and the study was ap-
proved by the University of Tasmania Human Research
Ethics Committee.
Study protocol
Participants attended the testing laboratory on two occa-
sions and were scheduled for MRI assessment. At visit 1,
participants were in a post-absorptive state and anthropo-
metric measures, questionnaires relating to BP, medical
history and hemodynamic data were recorded. Following
10 minutes of semi-recumbent rest (torso at 45°, arm sup-
ported at heart level), brachial BP was measured by a vali-
dated automatic device (Omron HEM-907; Hoofddorp,
The Netherlands) [21], followed by central hemodynamic
variables recorded by applanation tonometry (Sphygmo-
Cor, AtCor Medical, Sydney, Australia). All measures were
repeated during moderate intensity exercise at 60% of age-
predicted maximal heart rate. A validated [22] mercury
free sphygmomanometer (UM-101, A&D Medical, Tokyo,
Japan) and auscultation was used to measure exercise
brachial BP. Details of the exercise protocol have been
described elsewhere [18]. Non-invasive impedance cardi-
ography was continuously recorded throughout the proto-
col (PhysioFlow; Manatec Biomedical; Macheren, France).
At visit 2, fasting venous bloods were taken and partici-
pants were fitted with a 24-hour ambulatory BP monitor
(24ABPM; TM-2430, A&D Medical, Sydney, Australia).
Hypertension was defined as clinic brachial BP ≥140/
90 mmHg, self-reported diagnosis by a physician, or use
of antihypertensive medications.
MRI analysis
Scans were performed on a 1.5 T General Electric Signa
Excite T scanner with the following sequences: High-
resolution T1 weighted spoiled gradient echo (TR 35 ms,
TE 7 ms, flip angle 35°, field of view 24 cm, voxel size
1 mm3) comprising 120 contiguous slices; T2 weighted
fast spin echo (TR 4300 ms; TE 120 ms; NEX 1; turbo
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8802 ms, TE = 130 ms, TI = 2200 ms, voxel size 0.50 ×
0.50 × 3 mm). Scans were registered to a 152 brain
Montreal Neurological Institute template in stereotaxic
coordinate space. Brain tissue was classified as gray or
white matter using statistical parametric mapping software
SPM5. Hippocampi were manually segmented using
standard landmarks with high test-retest reliability [23].
WML were segmented using a validated semi-automated
method [24]. Gray matter (GMV), white matter, WML,
and hippocampal volumes were calculated using standard
voxel counting algorithms. MRI examiners were blinded
to outcome variables and diabetes status.
Central hemodynamic measures
Aortic reservoir characteristics
Central (aortic) pressure waveforms were reconstructed as
previously described [25]. Using custom MatLab software
the averaged radial pressure waveforms were separated into
reservoir pressure (representative of the cyclic changes in
aortic volume that occur during systolic expansion to store
blood, and diastolic recoil to allow for the discharge of
blood from the proximal aorta) and excess pressure (excess
work done by the left ventricle, see Figure 1) [10,11]. Reser-
voir pressure was calculated as previously described [13]
and Pexcess was determined by subtracting the reservoir
pressure from the aortic pressure waveform [26].
Central BP and aortic stiffness
Central BP was measured in duplicate and augmentation
index (AIx), augmented pressure (AP), pulse pressure
(PP) and PP amplification were calculated [25]. Right sided
carotid-to-femoral aPWV was measured as previously
described [18].
Cardiothoracic bioimpedance
Measures of cardiac output, systemic vascular resistance,
heart rate and stroke volume were recorded using a device
with good reproducibility during rest and exercise [27].
Five minutes of continuous steady state monitoring was
averaged and analyzed offline.
Peripheral hemodynamics
Duplicate conventional brachial BP measures were aver-
aged for analysis. 24ABPM was measured every 20 minutes
during the daytime, and every 30 minutes during the
nighttime.
Biochemistry
Fasting blood glucose, insulin, glycated hemoglobin (HbA1c),
and lipid profiles were obtained by accredited laboratory
techniques (Royal Hobart Hospital pathology department).
A resting urine sample was analyzed for the presence of al-
bumin by the Royal Hobart Hospital pathology department.Statistical analysis
Data were analyzed using SPSS for Windows software
version 19.0 (IBM SPSS Statistics, New York, USA). Data
were visually inspected for normality of distribution and
were all normally distributed. All brain volume outcome
measures were expressed as a ratio of total intracranial
volume. To compare characteristics between patients with
T2DM and healthy participants, independent t-tests (con-
tinuous variables) and Chi square tests (dichotomous
variables) were performed. Independent t-tests were
used to compare unadjusted brain volumes between
groups, followed by analysis of covariance (ANCOVA)
adjusted for age and sex. To assess the relationships
between resting and exercising central hemodynamic
variables and brain volumes, Pearson’s correlations
and multivariable linear regression were performed. Z
statistic scores were determined to compare the regression
slopes obtained from within-group correlations. Indepen-
dent variables known (age and sex) or suspected (heart
rate, ambulatory daytime systolic BP [SBP], body mass
index [BMI] and total cholesterol) to contribute to vari-
ance in brain volumes were added separately into the
regression model, and a p < 0.05 was considered statisti-
cally significant. Based on previous reproducibility work
[28], we calculated that a between-group difference of
10 mmHg in central SBP could be detected in 36 partici-
pants per group (α = 0.05 and β = 0.20), therefore we
recruited 40 participants for each group.
Results
Sample characteristics
One patient with T2DM and two healthy participants
withdrew consent for MRI due to claustrophobia. Brain
volume data was unavailable for one patient with T2DM
(due to a significant non-vascular abnormality on MRI)
and technical difficulty rendered aortic reservoir data
unavailable in two participants (one participant from
each group), resulting in 37 participants in each group.
Compared with healthy participants, patients with
T2DM were older, heavier, and had greater blood
glucose and (HbA1C). None of the healthy participants
were on BP or cholesterol lowering medications
(Table 1).
Table 2 summarizes the difference in brain volumes
between groups whilst Table 3 summarizes the differences
in resting and exercising central hemodynamics. There
was no difference between the groups in any of the ad-
justed brain volumes. Those with T2DM had significantly
greater values in most aortic reservoir characteristics and
other hemodynamic variables at rest and during exercise.
No between-group differences were observed for reservoir
pressure integral and stroke volume during rest and
exercise, and for peak reservoir pressure and cardiac
output during exercise alone. Compared with healthy






Male, n (%) 17 (47) 19 (51) 0.56
Age (years) 63 ± 9 52 ± 8 <0.001
Body mass index (kg/m2) 30.5 ± 4.8 25.9 ± 3.3 <0.001
Waist:hip (ratio) 0.91 ± 0.06 0.84 ± 0.1 0.002
Current smoker, n (%) 3 (8) 3 (8) 0.97
Hypercholesterolemia, n (%) 25 (66) 10 (27) 0.001
Normotensive, n (%) 15 (39) 28 (76) 0.002
24ABPM systolic BP (mmHg) 134 ± 13 130 ± 11 0.21
24ABPM diastolic BP (mmHg) 75 ± 8 79 ± 6 0.016
Daytime systolic BP (mmHg) 138 ± 14 136 ± 13 0.50
Nighttime systolic BP (mmHg) 119 ± 12 113 ± 11 0.016
Duration of diabetes (years) 6 ± 6 - -
Antihypertensive medications,
n (%)
24 (63) 0 (0) <0.001
Oral hypoglycemic medications,
n (%)
26 (68) 0 (0) <0.001
Urinary albumin (mg/L) 9.00 ± 11.19 7.85 ± 7.59 0.60
Insulin, n (%) 5 (13) 0 (0) 0.016
Statin, n (%) 25 (66) 0 (0) <0.001
Glucose (mmol/L) 7.5 ± 1.8 4.7 ± 0.4 <0.001
Glycated hemoglobin (HbA1C) (%) 7.2 ± 0.8 5.5 ± 0.3 <0.001
Insulin (IU/mL) 10.2 ± 8.6 2.4 ± 4.7 <0.001
Total cholesterol (mmol/L) 4.4 ± 1.0 5.4 ± 1.0 <0.001
HDL cholesterol (mmol/L) 1.3 ± 0.4 1.6 ± 0.4 0.002
Triglycerides (mmol/L) 1.4 ± 0.6 1.0 ± 0.5 0.003
Data expressed as mean ± standard deviation or %. T2DM, type 2 diabetes
mellitus; 24ABPM, 24 hour ambulatory blood pressure monitoring; BP, blood
pressure; HDL, high density lipoprotein. P is for between group analyses.
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higher in those with T2DM at rest and during exer-
cise, whereas resting systemic vascular resistance was
significantly lower. Pexcess correlated with AP at rest in
patients with T2DM (r = 0.49, p = 0.001) and in healthy
participants at rest and during exercise (r = 0.58, p < 0.001Table 2 Brain magnetic resonance imaging (MRI) volumes in
participants
MRI variable T2DM Heal
Mean ± SD (n = 37) Mean
Gray matter volume (ml) 567.36 ± 77.81 607.8
White matter volume (ml) 583.92 ± 76.03 604.8
Left hippocampal volume (ml) 2.43 ± 0.37 2.55 ±
Right hippocampal volume (ml) 2.51 ± 0.36 2.56 ±
White matter lesion volume (ml) 3.34 ± 2.38 3.44 ±
Unadjusted MRI volumes are presented in the first two columns; β refers to standar
determined by ANCOVA and adjusted for age, sex and total intracranial volume. P vand r = 0.34, p = 0.032 respectively). In patients with
T2DM, there was a significantly greater change from rest
to exercise in peak excess pressure, central SBP, central
PP, aPWV, brachial SBP and brachial PP compared to
healthy participants (p < 0.05 for all).
Associations between central hemodynamic and brain
MRI volumes
In patients with T2DM, resting aortic reservoir character-
istics were not related to MRI volumes (p > 0.05 for all). In
healthy participants, there was an inverse correlation be-
tween resting Pexcess and GMV (r = −0.41, p = 0.011),
which remained after adjusting for age, sex, ambulatory
daytime SBP and heart rate (Table 4, Figure 2). Further
adjustment for BMI or urinary albumin did not atte-
nuate the association (β = −0.73−4, p = 0.028, β = −0.061−3,
p = 0.045 respectively) however, the addition of total chol-
esterol did (β = −0.58−4, p = 0.060). Adjusting for clinic
SBP (in the place of ambulatory daytime SBP), did not af-
fect the relationship between Pexcess and GMV (β = 0.075
−3,
95% CI −0.139−3 to −0.011−3, p = 0.023). There was a
between-group difference in the strength of the association
between resting Pexcess and GMV in patients with T2DM
compared to healthy participants (z = 2.08, p = 0.044,
Figure 2).
In patients with T2DM, but not in healthy partici-
pants, resting aPWV was inversely associated with GMV
(r = −0.45, p = 0.005) and remained associated after adjust-
ing for age, sex, ambulatory daytime SBP, heart rate
(Table 4) and the use of antihypertensive medication.
Additionally, adjusting for clinic SBP instead of ambula-
tory BP, did not affect the relationship between aPWV and
GMV (β = −0.009, 95% CI −0.015 to −0.002, p = 0.009).
Further adjustment for BMI, urinary albumin or total chol-
esterol did not alter the association (β = −0.007, p = 0.036,
β = −0.007, p = 0.050 and β = −0.006, p = 0.045 respect-
ively). There was no difference between healthy partici-
pants and patients with T2DM in the strength of the
association between aPWV and GMV (z = 1.76, p = 0.088).
Aortic reservoir characteristics were not related to
WML volume in either group (p > 0.05 for all). In healthypatients with type 2 diabetes mellitus (T2DM) and healthy




± SD (n = 37) β coefficient (95% CI)
1 ± 63.01 0.014 (−17.23, 21.21) 0.84
4 ± 80.53 −0.005 (−15.98, 14.48) 0.92
0.38 −0.019 (−0.17, 0.14) 0.86
0.39 0.046 (−0.14, 0.21) 0.70
2.39 −0.148 (−1.93, 0.54) 0.26
dized beta coefficient for the association between T2DM and MRI variables
alue is for relation of diabetes status with MRI variables.
Table 3 Differences in central and peripheral hemodynamic variables between patients with type 2 diabetes mellitus
(T2DM) and healthy participants at rest, during exercise and the change from rest to exercise















Peak reservoir pressure (mm Hg) 36 ± 8 32 ± 4 0.016 18 ± 10 15 ± 5 0.17 −19 ± 10 −17 ± 10 0.49
Reservoir pressure integral (Pa.s) 1872 ± 520 1869 ± 369 0.97 794 ± 485 694 ± 263 0.40 −1413 ± 570 −1441 ± 454 0.81
Peak excess pressure (mm Hg) 35 ± 9 30 ± 4 0.005 73 ± 16 58 ± 12 <0.001 37 ± 19 27 ± 11 0.013
Excess pressure integral (Pa.s) 630 ± 197 493 ± 98 <0.001 1644 ± 437 1255 ± 472 <0.001 970 ± 468 776 ± 470 0.079
Central systolic BP (mm Hg) 114 ± 11 103 ± 10 <0.001 132 ± 14 114 ± 13 <0.001 18 ± 12 11 ± 11 0.015
Central pulse pressure (mm Hg) 45 ± 9 37 ± 5 <0.001 52 ± 12 39 ± 7 <0.001 8 ± 9 2 ± 7 0.003
0.Pulse pressure amplification (ratio) 1.2 ± 0.1 1.3 ± 0.1 <0.001 1.5 ± 0.1 1.6 ± 0.1 0.007 0.26 ± 0.11 0.23 ± 0.09 0.37
Augmented pressure (mm Hg) 13 ± 4.8 8 ± 5 <0.001 9 ± 6 4 ± 4 <0.001 −4 ± 5 −4 ± 3 0.78
Augmentation index (%) 29 ± 6.8 21 ± 10 <0.001 17 ± 9 10 ± 6 0.001 −12 ± 7 −11 ± 6 0.68
Augmentation index (at 75 bpm) 23 ± 6 13 ± 11 <0.001 25 ± 9 14 ± 11 <0.001 0.8 ± 9 1 ± 7 0.73
*Adjusted augmentation index (%) 26 ± 6.7 23 ± 6.7 <0.001 14.6 ± 8.0 11.9 ± 7.9 <0.001 −11.6 ± 6.7 −11.5 ± 6.8 0.58
Aortic pulse wave velocity (m/s) 8.01 ± 2.16 6.29 ± 1.42 <0.001 9.73 ± 2.10 7.02 ± 1.43 <0.001 2.14 ± 2.59 0.32 ± 2.71 0.004
Heart rate (bpm) 64 ± 8 58 ± 8 0.001 92 ± 12 86 ± 12 0.043 27 ± 9 28 ± 9 0.58
Cardiac output (L/min) 5.24 ± 0.90 4.50 ± 0.73 <0.001 8.22 ± 1.54 7.91 ± 1.28 0.35 2.9 ± 1.3 3.4 ± 1.3 0.103
Stroke volume (mL) 82 ± 11 78 ± 15 0.26 90 ± 13 93 ± 14 0.36 7 ± 12 14 ± 11 0.017
Peripheral hemodynamics
Brachial systolic BP (mm Hg) 124 ± 12 114 ± 9 <0.001 155 ± 17 134 ± 14 <0.001 31 ± 13 20 ± 13 <0.001
Brachial diastolic BP (mm Hg) 68 ± 8 65 ± 6 0.064 77 ± 9 73 ± 9 0.097 8 ± 6 9 ± 8 0.93
Brachial pulse pressure (mm Hg) 55 ± 10 49 ± 5 0.002 78 ± 15 60 ± 10 <0.001 23 ± 11 11 ± 10 <0.001
Systemic vascular resistance (d.s.cm−5) 1369 ± 243 1503 ± 268 0.027 1004.38 ± 201 973 ± 157 0.45 −354 ± 206 −529 ± 247 0.001
Data expressed as mean ± standard deviation. BP, blood pressure. P is for between group analyses. *Augmentation index adjusted for age, sex, heart rate and height.
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hemodynamic variables associated with WML volume
(r = 0.46, p = 0.004 and r = 0.47, p = 0.003 respectively)
and remained related after adjusting for age, sex, am-
bulatory daytime SBP and heart rate (Table 4). Alter-
natively adjusting for clinic SBP, in the place of
ambulatory BP, did not attenuate the relationships be-
tween central PP and AIx with WML (β =0.122−3,
95% CI 0.013−3 to 0.230−3, p = 0.029 and β =8.354−5,
95% CI −0.018−3 to −0.149−3, p = 0.014 respectively).
Further adjustment for BMI, urinary albumin or total
cholesterol did not attenuate the association between
AIx and WML volume (β = 5.40−5, p = 0.037, β = 6.233−5,
p = 0.020 and β = 5.86−5, p = 0.025) or central PP and
WML volume (β = 9.83−5, p = 0.025, β = 0.120−3, p = 0.007
and β = 0.0001, p = 0.006 respectively). Neither exercise
central hemodynamic variables nor the peripheral he-
modynamic variables were associated with MRI brain
volumes in either group.
Discussion
To our knowledge, this is the first study to examine as-
sociations between aortic reservoir characteristics andbrain structure. There are several new or noteworthy
findings: 1) In healthy individuals, Pexcess (a novel marker
of cardiovascular risk) was independently associated with
GMV. 2) In patients with T2DM, aortic stiffness (a more
traditional marker of cardiovascular risk and shown to
be elevated in patients with T2DM) was independently
associated with GMV. 3) Contrary to expectation, exer-
cise hemodynamic variables were not stronger correlates
of brain structural abnormalities than resting variables.
Overall, these findings suggest that central hemodynamic
mechanisms may play a role in leading to structural brain
changes underlying cognitive impairment, but that these
mechanisms may differ between healthy individuals and
patients with T2DM.
Unique to the brain is the continuous passive perfu-
sion of high volume blood flow to the organ throughout
systole and diastole [29]. High flow associated with low
microvascular resistance could lead to brain vascular
networks being sensitive to upstream changes in pres-
sure and flow pulsatility [30,31]. Maintenance of rela-
tively low central BP (especially PP) could, therefore, be
important in protecting the microcirculation from excess
pressure and/or flow pulsatile energy which may lead to
Table 4 Multivariable analysis of resting hemodynamics and gray matter volume in patients with type 2 diabetes
mellitus (T2DM) and healthy participants




Aortic pulse wave velocity −0.007 (−0.014, −0.050−2) −0.47 0.036 0.16
Age −0.001 (−0.002, 0.001) −0.15 0.44
Sex 0.006 (−0.019, −0.030) 0.088 0.64
24ABPM daytime systolic BP 2.94−5 (−0.001, 0.001) 0.013 0.94




Excess pressure integral 0.60−4 (−0.119−3, −0.200−5) −0.23 0.043 0.68
Age −0.020 (−0.002, −0.001) −0.49 <0.001
Sex −0.028 (−0.039, −0.018) −0.55 <0.001
24ABPM daytime systolic BP 4.30−5 (−0.390−3, 0.477−3) 0.021 0.84
Heart rate 0.32−4 (−0.001, 0.001) −0.010 0.93
White matter lesion/total
intracranial volume
Augmentation index 5.91−5 (0.9−5, 0.12−3) 0.52 0.021 0.16
Age 2.01−5 (0.29−4, 0.7−4) 0.14 0.41
Sex 0.28−3 (−0.001, 0.001) 0.12 0.57
24ABPM daytime systolic BP −0.10−4 (−0.39−4, 0.22−4) −0.093 0.58
Heart rate 9.17−6 (−0.41−4, 0.59−4) 0.060 0.71
Central pulse pressure 0.11−3 (0.28−3, 0.19−3) 0.48 0.010 0.19
Age 2.79−5 (−0.18−4, 0.74−4) 0.19 0.23
Sex 0.12−3 (−0.001, 0.001) −0.045 0.79
24ABPM daytime systolic BP 0.17−4 (−0.49−4, 0.14−4) −0.093 0.58
Heart rate 1.40−5 (−0.35−4, 0.63−4) 0.091 0.57
R2 refers ANOVA adjusted R square and P value is for the independent variable. 24ABPM, 24 hour ambulatory blood pressure monitoring; BP, blood pressure.
All models adjusted for age, sex, ambulatory daytime systolic BP and heart rate.
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changes [30]. This hypothesis appears to be consistent
with data in our study showing an independent associ-
ation of WML (a marker of small cerebral vessel disease)
with raised central PP and AIx in healthy people. More-
over, we show that higher Pexcess is related to lower GMV
in this population. Pexcess is representative of the excess
left ventricular work required above the minimum to eject
blood into the aorta and the Pexcess waveform has been
shown to correspond closely with the flow velocity
waveform [10,11,13,26]. Thus one interpretation of the
association between high Pexcess and low GMV is that
greater pressure and/or flow transmission from the
aorta to the cerebral circulation causes microvascular
stress [5], unfavorable remodeling leading to ischemia
[30] and neuronal loss.
Despite patients with T2DM being significantly older, of
greater BMI and aortic stiffness compared to controls,
there were no significant differences between the groups in
any of the brain volume measures. This may be explained
by the relatively small sample size or by the relatively
younger age and shorter duration of T2DM than that of
previous studies showing a significant reduction in brainvolume compared to non-diabetic individuals [32,33]. On
the other hand WML volume has been shown to not differ
between patients with T2DM and age and sex matched
controls [34]. Interestingly, the relationship between high
Pexcess and low GMV was only evident in healthy individ-
uals, whereas adverse structural brain changes were more
highly related to aortic stiffness in patients with T2DM.
These results may be influenced by the cross sectional
design of the study, but it is also likely that alterations in
central hemodynamic function associated with T2DM is
an explanatory factor. Key differences in patients with
T2DM compared with healthy individuals were in-
creased aortic stiffness, higher cardiac output (mainly
due to higher heart rate) and reduced systemic vascular
resistance. Increased aortic stiffening has previously been
described in these patients, and other study samples have
observed similar high left ventricular flow output
[35], reduced peripheral resistance and different central
hemodynamic responses to postural stress [25,36]. The
association between aortic stiffness and brain structural
defects has not been definitively established in patients
with T2DM despite some studies showing evidence for
[37], however also against [38], an association with
Figure 2 Univariate association (unadjusted) between excess pressure integral and gray matter volume in patients with type 2 diabetes
mellitus (T2DM) and healthy participants at rest.
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patients with type 1 diabetes mellitus [39] and the general
community in which aortic stiffening was independently
related to brain structural defects [30,31].
We can only speculate as to possible mechanistic
differences explaining brain atrophy between healthy
participants and those with T2DM. During systole,
pressure rises due to increased aortic inflow relative to
outflow [11]. A proportion of the pressure rise is dispersed
via aortic reservoir function which is dependent on prox-
imal aortic stiffness and peripheral resistance, both aiding
in buffering BP fluctuations to allow steady blood flow to
the periphery. Aortic reservoir pressure integral was not
different in those with T2DM compared with healthy con-
trols despite higher cardiac output and increased aortic
stiffness in the former. This is similar to previous reports
whereby patients with T2DM were shown to have reduced
aortic elastic properties, however, there was no difference
in aortic energy loss compared to non-diabetic controls
[40]. This implies that the significant reduction insystemic vascular resistance in patients with T2DM may
be a factor mitigating excessive increases in aortic reser-
voir pressure. Alternatively, or in conjunction, despite
some studies showing smaller aortic root diameter in pa-
tients with T2DM [41], aortic diameter could have remod-
eled to be higher in patients with T2DM in the current
study, thereby enabling relatively more inflow into the
proximal aorta before a rise in pressure occurs. Others
have suggested that alterations in aortic, rather than ca-
rotid arterial properties occur in patients with T2DM
[42,43]. Impedance mismatching between the aortic and
carotid arteries have previously been associated with in-
creased flow pulsatility in the carotid vasculature and may
relate to cerebral microvascular remodeling and lower
brain volumes [30]. Similarly, our data supports the prob-
ability that brain structural defects associated with aortic
stiffness in patients with T2DM may be the product of
excessive transmission of flow (rather than pressure) pul-
satility to the cerebral circulation. Therapeutic methods
(such as weight loss and reductions in insulin) that target
Climie et al. Cardiovascular Diabetology 2014, 13:143 Page 8 of 9
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tients with T2DM.
Finally, and in opposition to our hypothesis, associa-
tions between exercise aortic reservoir characteristics
and brain atrophy/WML were not enhanced compared
to resting data, despite patients with T2DM having exag-
gerated hemodynamic responses indicative of central
systolic stress (including increased central PP, AIx and
aPWV) compared to healthy individuals. This was based
on the expectation that moderate exercise (similar to
ambulatory BP conditions) would be more representative
of the chronic hemodynamic loading experienced during
normal daily activity and, thus, would be more highly
related to end organ disease. This appears to be relevant
to cardiac structure [45] and kidney function [18] but
the lack of relationship with brain morphology implies
different pathophysiological pathways.
The strengths of our study include comprehensive
MRI measures and rigorous hemodynamic examination
at rest and during moderate intensity exercise. Despite
finding significant associations between central hemody-
namic variables and GMV in both patients with T2DM
and healthy participants, we have performed multiple
statistical tests in a relatively small study sample and,
therefore, further studies in larger samples are required to
confirm our results. We did not measure aortic root diam-
eter and, therefore, our assumption of aortic dilation can-
not be confirmed. Furthermore, the cross sectional nature
of the study limits inference regarding causality.Conclusions
In summary, this is the first study to examine associa-
tions between aortic reservoir characteristics and brain
structure. Our findings suggest that Pexcess may be an
important contributor to brain atrophy in healthily age-
ing individuals whereas in patients with T2DM, aortic
stiffening may play a more prominent role. These findings
suggest that there may be different vascular abnormal-
ities contributing to brain dysfunction among diabetics
compared with non-diabetics. However more work is
required to determine the underlying central vascular
mechanism/s.
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